{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1116.388",
  "meta" : {
    "versionId" : "4",
    "lastUpdated" : "2018-04-03T15:48:57.000-04:00"
  },
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.388",
  "version" : "20171129",
  "name" : "No Adjuvant Hormonal Therapy Prostate",
  "status" : "active",
  "date" : "2017-11-29T01:00:05-05:00",
  "publisher" : "American Society of Clinical Oncology Steward",
  "compose" : {
    "include" : [{
      "system" : "http://www.ama-assn.org/go/cpt",
      "version" : "2022",
      "concept" : [{
        "code" : "1P",
        "display" : "Performance Measure Exclusion Modifier due to Medical Reasons"
      },
      {
        "code" : "2P",
        "display" : "Performance Measure Exclusion Modifier due to Patient Reasons"
      },
      {
        "code" : "4164F",
        "display" : "Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:bdfad0f2-2dfa-43ca-b1ba-1bfc199ce891",
    "timestamp" : "2022-09-27T23:16:37-04:00",
    "total" : 3,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.ama-assn.org/go/cpt",
      "version" : "2022",
      "code" : "1P",
      "display" : "Performance Measure Exclusion Modifier due to Medical Reasons"
    },
    {
      "system" : "http://www.ama-assn.org/go/cpt",
      "version" : "2022",
      "code" : "2P",
      "display" : "Performance Measure Exclusion Modifier due to Patient Reasons"
    },
    {
      "system" : "http://www.ama-assn.org/go/cpt",
      "version" : "2022",
      "code" : "4164F",
      "display" : "Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)"
    }]
  }
}